Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA approves Kerendia for chronic kidney disease linked to type 1 diabetes


Bio Techne shareholders approve acquisition by Merck KGaA


Körber certifies ZETA’s INOSIM Foresight for PAS X MES data integration


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Digitally Transforming Pharmaceutical Process Development and Manufacturing: Enabling Technologies for a Sustainable Future

Presented by Moiz Diwan, Moiz Diwan, Ph.D. Process Research and Development, AbbVie Inc., North Chicago, IL
04th October 2022


End User Perspective on Setting in-Process Endotoxin Limits

Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018


An impurity detected in a stability study: Did we miss anything in our E&L risk assessment?

Presented by Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe
15th March 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia